News & Perspective

Oct 28, 2010

Oct 28, 2010

First clinical trial results for norovirus vaccine outlined

(CIDRAP News) – In the first clinical trial of a norovirus vaccine—in which volunteers were deliberately exposed to the common gastrointestinal virus—the inoculation reduced participants' risk of illness by 47%, according to results released recently by LigoCyte Pharmaceuticals, Inc.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»